Correlation Between Syndax Pharmaceuticals and Tourmaline Bio

Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Tourmaline Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Tourmaline Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Syndax Pharmaceuticals and Tourmaline Bio, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Tourmaline Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Tourmaline Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Tourmaline Bio.

Diversification Opportunities for Syndax Pharmaceuticals and Tourmaline Bio

0.35

Correlation Coefficient

Syndax Pharmaceuticals  Tourmaline Bio

Weak diversification

The 3 months correlation between Syndax and Tourmaline is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Tourmaline Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tourmaline Bio and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Tourmaline Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tourmaline Bio has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Tourmaline Bio go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Tourmaline Bio

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 2.52 times less return on investment than Tourmaline Bio. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 1.78 times less risky than Tourmaline Bio. It trades about 0.14 of its potential returns per unit of risk. Tourmaline Bio is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  2,213  in Tourmaline Bio on July 31, 2025 and sell it today you would earn a total of  2,585  from holding Tourmaline Bio or generate 116.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Syndax Pharmaceuticals  vs.  Tourmaline Bio

Syndax Pharmaceuticals

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Syndax Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating fundamental indicators, Syndax Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Tourmaline Bio

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Tourmaline Bio are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite weak primary indicators, Tourmaline Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Syndax Pharmaceuticals and Tourmaline Bio

The main advantage of trading using opposite Syndax Pharmaceuticals and Tourmaline Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Tourmaline Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tourmaline Bio will offset losses from the drop in Tourmaline Bio's long position.

The idea behind Syndax Pharmaceuticals and Tourmaline Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.